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Hypoxia plays a crucial role in the pathogenesis of cardiovascular diseases. Mitochondrial 
enzyme arginase type II (Arg-II) is reported to lead to endothelial dysfunction and enhance 
the expression of endothelial inflammatory adhesion molecules such as intercellular adhesion 
molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1). In this study, 
we investigate the role of Arg-II in hypoxia-induced endothelial activation and the potential 
underlying mechanisms. Exposure of the human endothelial cells to hypoxia induced a time-
dependent increase in Arg-II, HIF1α, HIF2α, and ICAM-1 protein level, whereas no change in 
the protein level of VCAM-1 and E-selectin was observed. Similar effects were obtained in 
cells treated with a hypoxia mimetic Dimethyloxaloylglycine (DMOG). Silencing HIF1α, but 
not HIF2α, reversed hypoxia-induced upregulation of Arg-II. Moreover, silencing Arg-II 
prevented the ICAM-1 upregulation induced by hypoxia or DMOG. Furthermore, the endothelial 
cells incubated under hypoxic condition or treated with DMOG or hypoxia enhanced monocyte 
adhesion, which was inhibited by silencing Arg-II. Lastly, silencing Arg-II prevented hypoxia-
induced mitochondrial superoxide production in endothelial cells, and hypoxia-induced ICAM-1 
upregulation was reversed by mitochondrial electron transport inhibitor rotenone. These data 
demonstrate that hypoxia enhances ICAM-1 protein level and monocyte-endothelial interaction 
through HIF1α-mediated increase in Arg-II protein level on leading to increased mitochondrial 
reactive oxygen species production. These effects of hypoxia on endothelial cells may play a 
key role in cardiovascular diseases. Our results suggest that Arg-II could be a promising 
therapeutic target to prevent hypoxia-induced vascular damage/dysfunction.
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INTRODUCTION
Chronic hypoxia plays a key role in the pathophysiology of cardiovascular diseases including 
hypertension, atherosclerosis, and heart failure (Hulten and Levin, 2009; Bosc et  al., 2010; Abe 
et al., 2017). Hypoxia-inducible factors (HIFs) are well-characterized master regulators combating 
hypoxia-induced tissue injury by upregulating expression of many genes including erythropoietin, 
VEGF and glycolytic enzymes, which leads to compensatory increase in the oxygen supply and 
energy production. However, there is increasing evidence that HIFs also play a key role in the 
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pathophysiology of cardiovascular dysfunction through reducing 
endothelium-derived protective nitric oxide (NO) (Cowburn 
et  al., 2016), promoting vascular inflammation (Williams and 
Scharf, 2007; Ben-Shoshan et  al., 2009), senescence (Gaspar 
et  al., 2017), and apoptosis (Lee et  al., 2005), which leads to 
vascular diseases. Dissecting HIF-regulated pathways governing 
the beneficial and detrimental effects would thus shed light for 
specific targeting of the later pathways while preserving the former.
Arginase is an enzyme metabolizing L-arginine to L-ornithine 
and urea (Yang and Ming, 2013). There are two isoforms, 
namely arginase-I (Arg-I) and arginase-II (Arg-II). Arg-I is 
mainly expressed in hepatocytes and Arg-II in the kidney. Arg-I 
is located in the cytosol, whereas Arg-II is in the mitochondria. 
Notably, Arg-II is the main isoform that is inducible in human 
endothelial cells (Yang and Ming, 2013). Genome-wide analysis 
of HIF1-binding sites by ChIP-seq in endothelial cells identified 
that Arg-II gene intron 2 has HIF1-binding regions (Mimura 
et  al., 2012). Studies show that Arg-II is indeed upregulated 
in response to hypoxia in endothelial cells, which contributes 
to hypoxia-triggered reduction in NO generation and hypertension 
(Krotova et  al., 2010; Prieto et  al., 2011; Cowburn et  al., 2016; 
Pandey et  al., 2018). This hypoxia-induced upregulation of 
Arg-II has been shown to be mediated through HIF2α (Krotova 
et al., 2010; Cowburn et al., 2016). Moreover, Arg-II was reported 
to be  upregulated by hypoxia in pulmonary artery VSMC 
resulting in proliferation of the cells (Xue et  al., 2017). These 
provide compelling evidence that Arg-II is a HIF-inducible 
gene in regulating endothelial NO production and VSMC 
proliferation under hypoxic condition. It has been shown that 
endothelial expression of adhesion molecules including vascular 
cell adhesion molecule-1 (VCAM-1) and intercellular adhesion 
molecule-1 (ICAM-1) is upregulated by both HIF1α and HIF2α 
(Ben-Shoshan et  al., 2009). However, a role of Arg-II in 
endothelial activation regulated by HIFs remains unknown.
Compelling evidence including our own has been provided 
in recent years for an important role of Arg-II, the dominant 
isoenzyme in human and mouse vasculature, in cardiovascular 
diseases (Yang and Ming, 2014). It is now well recognized 
that an enhanced activity and/or expression of Arg-II in 
endothelial cells compete(s) with eNOS for L-arginine, resulting 
in eNOS-uncoupling, whereby eNOS produces superoxide anion 
instead of NO (Yepuri et  al., 2012). This mechanism plays an 
important role in endothelial dysfunction under pathological 
conditions such as atherosclerosis, type-II diabetes as well as 
in aging (Yepuri et  al., 2012; Xia et  al., 2017). Moreover, 
we  have recently demonstrated that Arg-II plays an important 
role in promoting mitochondrial dysfunction in senescent and 
apoptotic vascular cells, contributing to atherosclerotic 
vulnerability phenotype in a mouse model (Xiong et al., 2013). 
Elevated Arg-II in macrophages in obese mice promotes 
macrophage pro-inflammatory responses in insulin resistance 
and atherosclerosis (Ming et  al., 2012).
Given the promoting effects of Arg-II on mitochondrial 
dysfunction and endothelial activation as well as the enhanced 
Arg-II expression induced by HIFs, we hypothesize that hypoxia-
HIF-induced Arg-II in endothelial cells promotes endothelial 
activation through enhanced mitochondrial oxidative stress.
MATERIALS AND METHODS
Materials
Reagents were purchased or obtained from the following sources: 
rabbit antibodies against Arg-II (sc-20151) and E-selectin 
(sc-14011) and mouse antibody ICAM-1 (sc-8439) were from 
Santa Cruz Biotech (Dallas, USA); mouse antibodies against 
tubulin (T5168) and β-actin (A5441) and Dimethyloxaloylglycine 
(DMOG) were from Sigma (St. Louis, Missouri, USA); anti-
VCAM-1 (12367S) was from Cell Signaling Technology (Danvers, 
USA); mouse antibody against HIF1α (610958) was from BD 
Biosciences (New Jersey, USA); rabbit antibody against HIF2α 
(PAB12124) was from Abnova (Taipei, Taiwan); Alexa fluor 
680 conjugated anti-mouse IgG (A21057), MitoSox, and Hoechst 
33342 were from Invitrogen/Thermo Fisher Scientific (Waltham, 
MA USA); IRDye 800-conjugated anti-rabbit IgG (926-32211) 
was from LI-COR Bioconcept (Lincoln, USA); endothelial cell 
growth supplement (ECGS) pack was from PromoCell GmbH 
(Heidelberg, Germany); and all cell culture media and materials 
were from Gibco/Thermo Fisher Scientific (Waltham, MA USA).
Recombinant Adenovirus
The recombinant adenovirus (rAd) expressing shRNA targeting 
human Arg-II driven by the U6 promoter (rAd/U6-hArg-IIshRNA) 
and control rAd expressing shRNA targeting LacZ (rAd/
U6-LacZshRNA) were generated as described previously (Yepuri 
et  al., 2012). Generation of rAd expressing shRNA targeting 
human HIF1α and HIF2α driven by the U6 promoter (rAd/
U6-hHIF1αshRNA and rAd/U6-hHIF2αshRNA, respectively) was 
carried out with the Gateway Technology. The targeting sequences 
are in boldface below (only the sense strand is shown): 
GCCGAGGAAGAACTATGAACA for human HIF1α; CGACC 
TGAAGATTGAAGTGAT for human HIF2α.
Cell Culture and Adenoviral Transduction 
of the Cells
Preparation and culture of human umbilical vein endothelial 
cells (HUVECs) as well as the transduction of HUVECs by 
recombinant adenovirus were performed as described previously 
(Yepuri et  al., 2012). Hypoxic conditions were achieved by 
placing the culture dishes or plates in a Coy In Vitro Hypoxic 
Cabinet System (The Coy Laboratory Products, Grass Lake, 
MI USA) at 0.2% O2 with 5% CO2 and N2 as balance.
Immunoblotting
Cell lysate preparation, SDS-PAGE and immunoblotting, antibody 
incubation, and signal detection were conducted as previously 
described (Ming et  al., 2012). Quantification of the signals 
was performed using Li-Cor Image Studio Software.
Monocyte Adhesion to Endothelial Cells
Adhesion assay was performed as described previously (Ming 
et al., 2012). Briefly, the THP-1 cells (a human monocytic cell line) 
were cultured in RPMI-1640 containing 10% heat-inactivated 
fetal bovine serum (FBS). For adhesion assays, the THP-1 cells 
were labeled with CFDA-SE (5 μmol/L) in PBS at 37°C for 8 min, 
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and the labeling was stopped with 1  ml of heat-inactivated FBS 
for 1  min. The labeled monocytes (4  ×  105 THP-1) were then 
added to the HUVECs that were transduced with recombinant 
adenoviruses expressing shRNA and cultured under normoxic 
or hypoxic conditions, or treated with or without DMOG 
(1 mmol/L) for 24 h prior to the addition of labeled monocytes. 
After incubation for 15 min at 37°C, the non-adherent THP-1 cells 
were washed twice with PBS and fixed in 2% paraformaldehyde. 
The images of adherent monocytes were taken under the 
fluorescent microscope (five different fields per sample were 
captured). The number of adherent monocytes was counted 
using the Image J software (U.S. National Institutes of Health).
A
B
FIGURE 1 | Hypoxia increased mitochondrial superoxide production in HUVECs via inducing Arg-II protein level. The cells were transduced with rAd/U6-LacZshRNA 
as control or rAd/U6-Arg-IIshRNA to silence Arg-II gene, and then exposed to normoxia or hypoxia for 48 h. (A) Cells were then subjected to mitochondrial superoxide 
detection with MitoSox (red) followed by nuclei staining with Hoechst 33342 (blue). The images were taken through 10 × objectives with Zeiss fluorescence 
microscope directly after MitoSox staining without a post-staining fixation step. Scale bar = 50 μm. The merged images are also shown. The graph shows the 
quantification of the signals. Data are presented as mean ± SD. ****p < 0.0001 vs. corresponding shRNA-LacZ cells exposed to normoxia, ####p < 0.0001 vs. shRNA-
LacZ cells exposed to hypoxia. (B) Merged images of a higher resolution and magnification revealing the mitochondrial localization of the MitoSox signal. The images 
were taken from MitoSox staining with a post-staining fixation step through 40 × objectives with Leica TCS SP5 confocal laser microscope. Scale bar = 30 μm.
Liang et al. Arginase-II and Hypoxia-Induced Endothelial Inflammation
Frontiers in Physiology | www.frontiersin.org 4 August 2019 | Volume 10 | Article 1003
Detection of Mitochondrial Superoxide
Mitochondrial superoxide detection was performed by using 
MitoSox as described previously (Ming et  al., 2012; Chavan 
et  al., 2017). Briefly, the cells were incubated with MitoSox 
(5  μmol/L) for 10  min. After washing, the cells were 
counterstained with Hoechst 33342. Images were taken through 
10 × objectives with Zeiss fluorescence microscope. The intensity 
of the fluorescence was quantified by Image J software and 
normalized by cell number. For visualizing the mitochondrial 
localization of the MitoSox signal, after staining with MitoSox 
and washing, the cells were fixed with 3.7% of paraformaldehyde 
followed by counterstaining with Hoechst 33342 and then 
subjected to imaging through 40  ×  objectives with Leica TCS 
SP5 confocal laser microscope. Of note, the staining without 
a post-staining fixation step (for imaging using Zeiss fluorescence 
microscope shown in Figure 1A) shows similar results as that 
obtained from staining with a post-staining fixation step (for 
imaging using confocal microscope shown in Figure 1B), 
providing evidence that the post-staining fixation procedure 
does not introduce artifacts that may affect the results.
Statistical Analysis
In all experiments, n indicates the number of independent 
experiments. The Kolmogorov–Smirnov test was used to first 
determine whether the data deviate from Gaussian distributions. 
Since all data are normally distributed, statistical analysis was 
performed with the Student’s t-test for unpaired observations 
or ANOVA with Bonferroni’s post-test, and data are expressed 
as mean ± SD. Differences were considered statistically significant 
at p  <  0.05.
RESULTS
Hypoxia Increases Arginase Type II Protein 
Level in Endothelial Cells
To study the effect of hypoxia on Arg-II protein level in 
HUVECs, the cells were cultured under normoxic and 
hypoxic conditions for 6–72  h. The protein level of Arg-II 
in HUVECs was determined by immunoblotting. As shown 
in Figure 2A, hypoxia significantly enhanced Arg-II protein 
levels in a time-dependent manner. The Arg-II protein 
level was also enhanced in the cells treated with DMOG 
(Figure 2B), an agent that mimics hypoxic condition by 
inhibiting activity of prolyl-4-hydroxylase, resulting in 
HIFα accumulation. The results suggest a role of HIF in 
upregulation of Arg-II protein level in the endothelial cells 
under hypoxic condition.
A
B
FIGURE 2 | Hypoxia and DMOG enhanced Arg-II protein level in HUVECs. (A) HUVECs were cultured under hypoxic condition (0.2% O2) for indicated time, with 
matched control under normoxic condition. Immunoblotting shows hypoxia enhances the protein level of Arg-II. (B) The cells were treated with control medium or 
1 mmol/L DMOG for indicated time under normoxic condition. Immunoblotting indicates that DMOG increases Arg-II protein level. The graphs on the right show the 
quantification of the signals on immunoblots. Data are presented as mean ± SD. One-way ANOVA analyzing differences between each treatment group and the 
control group. **p < 0.01, ***p < 0.001, ****p < 0.0001 vs. control group.
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Hypoxia-Inducible Factor 1α Mediates 
Arginase Type II Upregulation  
Induced by Hypoxia
Indeed, both HIF1α and HIF2α levels were upregulated over 
72 h in the endothelial cells under hypoxic condition (Figure 3). 
The maximum elevation of HIFs occurred at 6  h of hypoxia 
and remained at significantly higher levels as compared with 
the normoxia controls (Figure 3A). As expected, DMOG treatment 
exerted similar effects on HIF levels in the cells (Figure 3B).
Next, the cells were transduced with recombinant adenovirus 
(rAd) carrying shRNA against human HIF1α (rAd/
U6-HIF1αshRNA) or HIF2α (rAd/U6-HIF2αshRNA) and were 
subjected to either normoxic or hypoxic condition. The 
specificity and efficiency of HIF1α and HIF2α silencing 
were confirmed by immunoblotting (Figures 4A,B). 
Interestingly, silencing HIF1α, but not HIF2α, prevented 
Arg-II upregulation in cells under hypoxic condition 
(Figure 4C). These results demonstrate that hypoxia-induced 
A B
FIGURE 3 | Hypoxia and DMOG upregulated HIF1α and HIF2α levels in HUVECs. (A) The cells were exposed to normoxia or hypoxia for indicated time. Exposure 
to hypoxia enhanced HIF1α and HIF2α protein level examined by immunoblotting. (B) The cells were treated with control medium or 1 mmol/L DMOG for indicated 
time. Treatment of the HUVECs with DMOG increases HIF1α and HIF2α protein level detected by immunoblotting. The graphs on the right show the quantification of 
the signals on immunoblots. Data are presented as mean ± SD. One-way ANOVA analyzing differences between each treatment group and the control group. 
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 vs. control group.
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upregulation of Arg-II in endothelial cells was mediated by 
HIF1α, but not HIF2α.
Hypoxia-Induced Intercellular Adhesion 
Molecule 1 Upregulation in Endothelial 
Cells Is Mediated by Arginase Type II
It is well recognized that increased endothelial adhesion 
molecule expression results in enhanced adhesion and 
transmigration of monocytes into the vascular wall. 
We examined whether hypoxia induces protein level of adhesion 
molecules such as VCAM-1, ICAM-1, and E-selectin in 
endothelial cells. The protein level of ICAM-1 was enhanced 
in endothelial cells under the hypoxic condition over 72  h 
in a time-dependent manner (Figure 5A). Furthermore, 
treatment of the cells with DMOG also enhanced ICAM-1 
protein level in the cells (Figure 5B). However, hypoxia did 
not induce VCAM-1 and E-selectin protein level in the 
endothelial cells (Figures 5C,D). Importantly, silencing Arg-II 
in the endothelial cells as validated by immunoblotting 
(Figure 6A) significantly reduced ICAM-1 upregulation by 
DMOG (Figure 6B). Similarly, protein level of ICAM-1 under 
hypoxic condition was significantly reduced in cells in which 
Arg-II gene was silenced (Figure 6C). These results suggest 
that hypoxia-induced upregulation of ICAM-1  in endothelial 
cells is mediated by Arg-II.
Silencing Arginase Type II in Endothelial 
Cells Inhibits Hypoxia-Induced  
Monocyte-Endothelial Cell Interaction
As a result of increased ICAM-1 protein level in endothelial 
cells under hypoxic condition, an increase in monocyte 
adhesion to the endothelial cells was observed. Indeed, in 
endothelial cells exposed to hypoxic condition, monocyte 
adhesion to the endothelial cells was significantly enhanced, 
which was inhibited by Arg-II silencing (Figure 7A). Of 
note, the phase contrast images reveal the similar plating 
density of endothelial cells. Similar results were obtained 
with DMOG treatment. DMOG significantly enhanced 
monocyte adhesion to endothelial cells, which was prevented 
by Arg-II silencing (Figure 7B). These findings indicate that 
hypoxia-induced monocyte adhesion to endothelial cells was 
mediated by endothelial Arg-II.
A B
C
FIGURE 4 | Silencing HIF1α prevented hypoxia-induced upregulation of Arg-II in HUVECs. HUVECs were transduced with rAd/U6-LacZshRNA as control 
or rAd/U6-HIF1αshRNA and rAd/U6-HIF2αshRNA to silence HIF1α and HIF2α gene, respectively. (A) Immunoblotting analysis confirms HIF1α silencing.  
(B) Immunoblotting analysis validates HIF2α silencing. (C) Immunoblotting shows silencing HIF1α, but not HIF2α, inhibited Arg-II upregulation in HUVECs induced  
by hypoxia. Graph on the right presents the quantification of the signals on immunoblots. Data are presented as mean ± SD. ***p < 0.001 vs. corresponding 
shRNA-LacZ cells cultured under normoxic condition, ##p < 0.01 vs. shRNA-LacZ cells incubated under hypoxic condition.
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Hypoxia Increases Intercellular Adhesion 
Molecule 1 Protein Level Through Arginase 
Type II and Mitochondrial Reactive Oxygen 
Species in Endothelial Cells
We further investigated roles of Arg-II in mitochondrial 
dysfunction and ICAM-1 protein level under hypoxic condition. 
As shown in Figure 1, hypoxia increased mitochondrial reactive 
oxygen species (ROS) production, which was prevented by 
silencing Arg-II in the endothelial cells, suggesting that hypoxia 
enhances mitochondrial ROS production through Arg-II in 
the cells. Furthermore, inhibition of mitochondrial respiration 
complex-I by rotenone prevented increase in ICAM-1 without 
significant effect on HIF1α under hypoxic condition (Figure 8A). 
Similar results were obtained for DMOG-induced ICMA-1 and 
HIF1α (Figure 8B).
DISCUSSION
Our current study confirms the previous findings that hypoxia 
is a potent stimulus for Arg-II protein level in endothelial cells 
(Krotova et  al., 2010; Prieto et  al., 2011; Cowburn et  al., 2016; 
Pandey et  al., 2018). Furthermore, we  provide evidence that this 
effect of hypoxia enhances monocyte-endothelium interaction due 
A B
C
D
FIGURE 5 | Hypoxia and DMOG increased ICAM-1 protein level in HUVECs. (A,C,D) HUVECs were incubated under normoxic or hypoxic condition (0.2% O2) for 
indicated time. Immunoblotting shows hypoxia enhances ICAM-1 protein level (A), but not VCAM-1 (C) and E-selectin (D) protein level. (B) The cells were treated 
with control medium or 1 mmol/L DMOG for 24 h under normoxic condition. Immunoblotting reveals that DMOG increases ICAM-1 protein level. Quantification of 
the signals on immunoblots is presented as graphs below. Data are presented as mean ± SD. One-way ANOVA analyzing differences between each treatment 
group and the control group (A) and t-test (B). **p < 0.01, ****p < 0.0001 vs. control group.
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to increased ICAM-1 protein level which is mediated by HIF1α-
Arg-II-mitochondrial ROS in endothelial cells exposed to hypoxia.
Under hypoxic condition, cellular adaptation oxygen-sensing 
pathways are activated, which relies on the transcription factor 
HIF. HIF is a dimeric protein complex composed of alpha and 
beta subunits. Under normoxic conditions, HIF1α and HIF2α 
are hydroxylated by the oxygen-dependent prolyl-hydrolase (PHD) 
leading to ubiquitination of HIF1α and HIF2α by the von 
Hippel–Lindau protein (VHL) E3 ubiquitin ligase and their 
subsequent rapid degradation (Semenza, 2014). Under hypoxic 
conditions, HIF-PHD interaction is inhibited, resulting in 
stabilization and accumulation of alpha subunit of HIFs, allowing 
transcription of hypoxia-driven target genes (Semenza, 2014). 
Arg-II has been demonstrated to be  one of the HIF-regulated 
A
B
C
FIGURE 6 | Silencing Arg-II in HUVECs prevented the ICAM-1 upregulation induced by hypoxia or DMOG. The cells were transduced with rAd/U6-LacZshRNA as 
control or rAd/U6-Arg-IIshRNA to silence Arg-II gene, and then treated with or without DMOG (1 mmol/L) for 24 h, or incubated under normoxic or hypoxic condition 
for 48 h. (A) Immunoblotting shows Arg-II silencing in HUVECs. (B) Silencing Arg-II in HUVECs reverses DMOG-induced increase in protein level of ICAM-1 analyzed 
by immunoblotting. (C) Silencing Arg-II abrogates hypoxia-induced increase in ICAM-1 level measured by immunoblotting. The plot graphs on the right present the 
quantification of the signals on immunoblots. Data are presented as mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001 vs. corresponding shRNA-LacZ group, 
#p < 0.05, ##p < 0.01, ###p < 0.001 vs. shRNA-LacZ cells treated with DMOG or cultured in the hypoxic condition.
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genes (Krotova et  al., 2010; Prieto et  al., 2011; Mimura et  al., 
2012; Cowburn et  al., 2016; Pandey et  al., 2018). In our current 
study, we  show that Arg-II upregulation in human endothelial 
cells is mediated by HIF1α, since hypoxia- and DMOG-induced 
Arg-II protein level is inhibited upon silencing HIF1α but not 
HIF2α. This is in line with the genome-wide analysis of HIF1-
binding sites by ChIP-seq in endothelial cells which reveals that 
Arg-II gene intron 2 has HIF1-binding regions (Mimura et  al., 
2012). It is, however, in contrast to previous studies showing 
that the hypoxia-induced upregulation of Arg-II is mediated 
through HIF2α in pulmonary endothelial cells (Krotova et  al., 
2010; Cowburn et al., 2016). The discrepancy of Arg-II upregulation 
through HIF1  in HUVEC in our current study or through 
HIF2 in pulmonary endothelial cells in previous studies (Krotova 
et  al., 2010; Cowburn et  al., 2016) may be  due to different 
origin of endothelial cells. The transcription factor Kruppel-like 
factor 15 (KLF15) has recently been shown to bind directly to 
the Arg-II promoter and repress endothelial Arg-II expression 
(Pandey et  al., 2018). Interestingly, KLF15 was decreased and 
binding of KLF15 to the Arg-II promoter was relieved in response 
to hypoxia. Moreover, overexpression of KLF15 reversed hypoxia-
induced augmentation of arginase activity in human pulmonary 
microvascular endothelial cells (HPMECs), suggesting that KLF15 
is a critical regulator of Arg-II transcription in response to 
hypoxia in HPMEC (Pandey et  al., 2018). Whether KLF15 
contributes to the Arg-II upregulation in HUVEC remains elusive.
Hypoxia is associated with inflammations (Eltzschig and 
Carmeliet, 2011; Abe et al., 2017). Studies showed that hypoxia 
induces endothelial activation with enhanced endothelial adhesion 
molecule expression (Yoon et al., 2006; Ben-Shoshan et al., 2009). 
Our present study confirmed upregulation of ICAM-1 by both 
hypoxia and hypoxia mimetic DMOG. VCAM-1 and E-selectin 
A
B
FIGURE 7 | Silencing Arg-II in HUVECs inhibited Hypoxia (A)- and DMOG (B)-enhanced monocyte adhesion. CFDA-SE fluorescence labeled THP-1 monocyte 
adhesion to endothelial cells that were transduced with shRNA as indicated. The phase contrast images reveal the similar plating density of endothelial cells. 
The plot graph shows quantifications of the adhered monocytes. Data are presented as mean ± SD. **p < 0.01, ***p < 0.001 vs. corresponding shRNA-LacZ group, 
##p < 0.01, ###p < 0.001 vs. shRNA-LacZ cells treated with DMOG. Scale bar = 100 μm.
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level is not affected by hypoxia. We  further demonstrate 
that hypoxia-induced ICAM-1 protein level is mediated 
through Arg-II. This conclusion is supported by the fact that 
the hypoxia- or DMOG-induced ICAM-1 protein level is 
inhibited upon silencing Arg-II. In support of this finding, 
hypoxia- or DMOG-induced monocyte adhesion to endothelial 
cells is also markedly abolished by silencing Arg-II. Since Arg-II 
is regulated by HIF1α, but not HIF2 α, in endothelial cells 
in response to hypoxia, our results suggest that hypoxia-induced 
endothelial activation is mediated by HIF1α which leads to 
A
B
FIGURE 8 | Mitochondrial electron transport inhibitor rotenone reversed hypoxia- and -DMOG-induced increase in ICAM-1 protein level without affecting HIF1α 
level in HUVECs. The cells were pretreated with or without rotenone (2 μmol/L) for 1 h and then incubated under normoxic or hypoxic condition (A) or treated with 
DMOG (B) for 48 h (A) or 24 h (B), respectively. The protein level of ICAM-1 and HIF1α in HUVECs was detected by immunoblotting. The graph on the right 
indicates the quantification of the signals. Data are showed as mean ± SD. *p < 0.05, ****p < 0.0001 between indicated groups.
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Arg-II upregulation. Interestingly, studies have demonstrated 
that HIF1α is induced by pro-inflammatory stimuli 
lipopolysaccharide (LPS) and interferon gamma (IFNγ) and 
plays a critical role in pro-inflammatory M1 macrophage 
activation (Cramer et al., 2003; Bonello et al., 2007; Rius et al., 
2008), whereas HIF2α is induced by anti-inflammatory stimuli 
IL-4 and IL-13 and expressed exclusively in anti-inflammatory 
M2 macrophage (Takeda et  al., 2010). Our data thus support 
a role ofHIF1α in pro-inflammatory response in endothelial 
cells in addition to that in M1 macrophages, and for the first 
time characterized Arg-II as a downstream mediator of HIF1α 
in the pro-inflammatory response.
Finally, we  provide evidence that HIF1α-Arg-II-mediated 
endothelial ICAM-1 upregulation under hypoxic condition 
involves mitochondrial ROS generation, since hypoxia-induced 
mitochondrial ROS generation is suppressed by Arg-II silencing 
and inhibition of mitochondrial ROS blocks hypoxia-induced 
ICAM-1. It has been reported that hypoxia-induced ROS 
production is mainly from mitochondria (Pearlstein et  al., 
2002), which is in line with our finding. Moreover, in supporting 
our finding of HIF1α-Arg-II-mitochondrial ROS cascade as a 
mechanism of hypoxia-induced endothelial ICAM-I protein 
level, previous studies have demonstrated that mitochondrial 
ROS increases ICAM-1 through AP-1 and NF-kB (Hawkins 
et  al., 2007; Li et  al., 2016). Furthermore, increased ROS 
generation has been shown to be  associated with leukocyte-
endothelial cell adhesion (Wood et  al., 2000). The fact that 
rotenone, an inhibitor of mitochondrial respiration chain, blocks 
hypoxia-induced ICAM-1 protein level induced by Arg-II 
suggests that Arg-II promotes mitochondrial ROS through 
affecting mitochondrial respiration chain. In contrast to the 
previous report showing that mitochondrial ROS stabilizes 
HIF1α during hypoxia (Chandel et  al., 2000), inhibition of 
mitochondrial ROS with rotenone did not affect HIF1α level 
either under hypoxic condition or under condition of DMOG 
treatment, indicating that mitochondrial ROS does not play a 
major role in regulation of HIF1α levels under our experimental 
condition. How Arg-II perturbs mitochondrial respiration chain 
requires further investigation.
CONCLUSION
Our study demonstrates that hypoxia enhances endothelial 
ICAM-1 protein level and monocyte-endothelium interaction 
through HIF1α-Arg-II-mitochondrial ROS (Figure 9). Our 
study reveals an important molecular and cellular mechanism 
of hypoxia-induced endothelial dysfunction and suggests that 
targeting HIF1α-Arg-II-mitochondrial ROS cascade could be  a 
promising therapeutic strategy to prevent hypoxia-induced 
vascular damage/dysfunction.
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